Cargando…
Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous
Proliferative vitreoretinopathy (PVR) with rhegmatogenous retinal detachment (RRD) is a complex inflammatory ocular disease. Statins are widely used cholesterol-lowering drugs with putative anti-inflammatory properties. In this study, we have explored their efficacy in controlling post-surgical PVR...
Autores principales: | Mysore, Yashavanthi, del Amo, Eva M., Loukovaara, Sirpa, Hagström, Marja, Urtti, Arto, Kauppinen, Anu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806714/ https://www.ncbi.nlm.nih.gov/pubmed/33441813 http://dx.doi.org/10.1038/s41598-020-80127-1 |
Ejemplares similares
-
Author Correction: Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous
por: Mysore, Yashavanthi, et al.
Publicado: (2021) -
Vitreoschisis‐induced vitreous cortex remnants: missing link in proliferative vitreoretinopathy
por: van Overdam, Koen
Publicado: (2019) -
Distinct Serum and Vitreous Inflammation-Related Factor Profiles in Patients with Proliferative Vitreoretinopathy
por: Ni, Yao, et al.
Publicado: (2020) -
Statin medication in patients with epiretinal membrane is associated with low intravitreal EPO, TGF-beta-1, and VEGF levels
por: Tuuminen, Raimo, et al.
Publicado: (2016) -
Increased Glial Fibrillary Acid Protein and Vimentin in Vitreous Fluid as a Biomarker for Proliferative Vitreoretinopathy
por: Lee, Sun Young, et al.
Publicado: (2020)